226
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Risk assessment of readmissions following an initial COPD-related hospitalization

, &
Pages 551-559 | Published online: 12 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (14)

Yan Shen Kee, Chee Kuan Wong, Muhammad Anis Abdul Aziz, Mohd Idzwan Zakaria, Fatimah Mohd Shaarif, Kee Seong Ng, Chong Kin Liam, Yong Kek Pang & Ee Ming Khoo. (2023) 30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2623-2631.
Read now
Dave Singh, Steve Holmes, Claire Adams, Mona Bafadhel & John R Hurst. (2021) Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3009-3016.
Read now
Yao-Kuang Wu, Wen-Lin Su, Mei-Chen Yang, Sin-Yi Chen, Chih-Wei Wu & Chou-Chin Lan. (2021) Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2475-2485.
Read now
Wilhelmine H Meeraus, Hana Mullerova, Céline El Baou, Marion Fahey, Edith M Hessel & William A Fahy. (2021) Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 225-244.
Read now
Wei-ping Hu, Tsokyi Lhamo, Dong Liu, Jing-qing Hang, Feng-ying Zhang, Yi-hui Zuo, Ying-ying Zeng & Jing Zhang. (2019) Development of a Nomogram to Predict the Risk of 30-Day Re-Exacerbation for Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 160-167.
Read now
Marco Mantero, Paola Rogliani, Marta Di Pasquale, Eva Polverino, Ernesto Crisafulli, Monica Guerrero, Andrea Gramegna, Mario Cazzola & Francesco Blasi. (2017) Acute exacerbations of COPD: risk factors for failure and relapse. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2687-2693.
Read now
Raju Bishwakarma, Wei Zhang, Yong-Fang Kuo & Gulshan Sharma. (2017) Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 477-486.
Read now
Xuehua Ke, Jessica Marvel, Tzy-Chyi Yu, Debra Wertz, Caroline Geremakis, Liya Wang, Judith J Stephenson & David M Mannino. (2016) Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1689-1703.
Read now
Raj Parikh, Trushil G Shah & Rajive Tandon. (2016) COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 577-583.
Read now
Tzy-Chyi Yu, Huanxue Zhou, Kangho Suh & Stephen Arcona. (2015) Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease. ClinicoEconomics and Outcomes Research 7, pages 37-51.
Read now
Sean D Candrilli, Amol D Dhamane, Juliana L Meyers & Shuchita Kaila. (2015) Factors associated with inpatient readmission among managed care enrollees with COPD. Hospital Practice 43:4, pages 199-207.
Read now
Ernesto Crisafulli, Antoni Torres, Arturo Huerta, Raúl Méndez, Mónica Guerrero, Raquel Martinez, Adamantia Liapikou, Néstor Soler, Sanjay Sethi & Rosario Menéndez. (2015) C-Reactive Protein at Discharge, Diabetes Mellitus and ≥1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:3, pages 311-320.
Read now
Christine L Baker, Kelly H Zou & Jun Su. (2014) Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 431-439.
Read now

Articles from other publishers (4)

Stefan Hadzic, Cheng-Yu Wu, Marija Gredic, Baktybek Kojonazarov, Oleg Pak, Simone Kraut, Natascha Sommer, Djuro Kosanovic, Friedrich Grimminger, Ralph T. Schermuly, Werner Seeger, Saverio Bellusci & Norbert Weissmann. (2021) The effect of long-term doxycycline treatment in a mouse model of cigarette smoke-induced emphysema and pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 320:5, pages L903-L915.
Crossref
Melissa H. Roberts, Douglas W. Mapel & Hans Petersen. (2019) Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease. Drugs - Real World Outcomes 7:1, pages 1-17.
Crossref
Denitza P. Blagev, Dave S. Collingridge, Susan Rea, Benjamin D. Horne, Valerie G. Press, Matthew M. Churpek, Kyle A. Carey, Richard A. Mularski, Siyang Zeng & Mehrdad Arjomandi. (2018) The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk. Frontiers in Medicine 5.
Crossref
Heba H. Hijazi, Mohammad S. Alyahya, Hanan M. Hammouri & Hussam A. Alshraideh. (2016) Risk assessment of comorbidities on 30‐day avoidable hospital readmissions among internal medicine patients. Journal of Evaluation in Clinical Practice 23:2, pages 391-401.
Crossref